Peter Yeh

Peter Yeh leads prospective clinical trials investigating the direct impact of bariatric surgery on cancer incidence, including contributions to the design and execution of randomized studies that aim to definitively establish the causal relationship between surgical weight loss and cancer prevention. His research on gastrointestinal cancer outcomes after bariatric surgery has addressed both the protective effects of weight loss and the potential risks of altered GI anatomy. He advocates for prospective trial evidence to support metabolic surgery cancer prevention indications.